Actively Recruiting
Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.
Led by Laval University · Updated on 2025-03-10
500
Participants Needed
5
Research Sites
159 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
* Improving patient comfort and implementing the protocols required to minimize the risk of RAO must be part of quality control. * Several procedural parameters are related to the risk of RAO but hemostasis is a critical period. * Despite the fact that non-occlusive hemostasis of the radial artery is a recognized and effective technique for reducing the risk of RAO, it is rarely practiced because it is tedious, involves additional care and is not always effective with current hemostasis systems. * Prophylactic compression of the cubital artery during radial artery hemostasis has been shown to be effective in maintaining non-occlusive hemostasis but requires 2 devices and does not simplify care procedures. * The Terry2™ band is a new dual device that offers effortless non-occlusive radial hemostasis and does not require repeated intervention by nursing staff. The primary objectives of this observational study are to demonstrate the benefits, safety and impact on care of using Terry2™ band in patients undergoing diagnostic or interventional catheterization by radial (or ulnar) approach.
CONDITIONS
Official Title
Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any patient referred for diagnostic or interventional catheterization through radial or cubital approach
You will not qualify if you...
- Unable to understand the study design and sign an informed consent
- Unable to receive antiplatelet therapy with aspirin and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant treatment with heparin or bivalirudin
- Presence of any local conditions like hematoma or pseudo-aneurysms precluding radial or cubital access
- Presence of PPG while simultaneously compressing the radial and cubital arteries, preventing non-occlusive hemostasis with the Terry212 band
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
CSSS Chicoutimi
Chicoutimi, Quebec, Canada, G7H 5H6
Not Yet Recruiting
2
CHUM- Centre hospitalier de l'Université de Montréal
Montreal, Quebec, Canada
Not Yet Recruiting
3
CHU de Québec
Québec, Quebec, Canada
Not Yet Recruiting
4
IUCPQ - Laval Hospital
Québec, Quebec, Canada
Actively Recruiting
5
Hôpital Sainte-Marie
Trois-Rivières, Quebec, Canada
Not Yet Recruiting
Research Team
T
Tomas A Cieza Lara, MD
CONTACT
M
Michèle Jadin
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here